guest ::
| Home > Publications Database > Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation. > print |
| Home > Publications Database > Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation. > print |
| 001 | 257582 | ||
| 005 | 20240403131749.0 | ||
| 024 | 7 | _ | |a pmc:PMC10115838 |2 pmc |
| 024 | 7 | _ | |a 10.1038/s42003-023-04813-2 |2 doi |
| 024 | 7 | _ | |a pmid:37076591 |2 pmid |
| 024 | 7 | _ | |a altmetric:146127347 |2 altmetric |
| 037 | _ | _ | |a DZNE-2023-00458 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Messelodi, Daria |0 P:(DE-2719)9000667 |b 0 |u dzne |
| 245 | _ | _ | |a Neuronopathic Gaucher disease models reveal defects in cell growth promoted by Hippo pathway activation. |
| 260 | _ | _ | |a London |c 2023 |b Springer Nature |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1684845939_10419 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Gaucher Disease (GD), the most common lysosomal disorder, arises from mutations in the GBA1 gene and is characterized by a wide spectrum of phenotypes, ranging from mild hematological and visceral involvement to severe neurological disease. Neuronopathic patients display dramatic neuronal loss and increased neuroinflammation, whose molecular basis are still unclear. Using a combination of Drosophila dGBA1b loss-of-function models and GD patient-derived iPSCs differentiated towards neuronal precursors and mature neurons we showed that different GD- tissues and neuronal cells display an impairment of growth mechanisms with an increased cell death and reduced proliferation. These phenotypes are coupled with the downregulation of several Hippo transcriptional targets, mainly involved in cells and tissue growth, and YAP exclusion from nuclei. Interestingly, Hippo knock-down in the GBA-KO flies rescues the proliferative defect, suggesting that targeting the Hippo pathway can be a promising therapeutic approach to neuronopathic GD. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Glucosylceramidase |0 EC 3.2.1.45 |2 NLM Chemicals |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Gaucher Disease: genetics |2 MeSH |
| 650 | _ | 2 | |a Gaucher Disease: metabolism |2 MeSH |
| 650 | _ | 2 | |a Gaucher Disease: therapy |2 MeSH |
| 650 | _ | 2 | |a Glucosylceramidase: genetics |2 MeSH |
| 650 | _ | 2 | |a Glucosylceramidase: metabolism |2 MeSH |
| 650 | _ | 2 | |a Hippo Signaling Pathway |2 MeSH |
| 650 | _ | 2 | |a Neurons: metabolism |2 MeSH |
| 650 | _ | 2 | |a Cell Proliferation |2 MeSH |
| 700 | 1 | _ | |a Strocchi, Silvia |0 0000-0003-1248-4498 |b 1 |
| 700 | 1 | _ | |a Bertuccio, Salvatore Nicola |b 2 |
| 700 | 1 | _ | |a Baden, Pascale |0 P:(DE-2719)2811884 |b 3 |u dzne |
| 700 | 1 | _ | |a Indio, Valentina |b 4 |
| 700 | 1 | _ | |a Giorgi, Federico M |0 0000-0002-7325-9908 |b 5 |
| 700 | 1 | _ | |a Taddia, Alberto |b 6 |
| 700 | 1 | _ | |a Serravalle, Salvatore |b 7 |
| 700 | 1 | _ | |a Valente, Sabrina |b 8 |
| 700 | 1 | _ | |a di Fonzo, Alessio |0 0000-0001-6478-026X |b 9 |
| 700 | 1 | _ | |a Frattini, Emanuele |b 10 |
| 700 | 1 | _ | |a Bernardoni, Roberto |b 11 |
| 700 | 1 | _ | |a Pession, Annalisa |b 12 |
| 700 | 1 | _ | |a Grifoni, Daniela |0 0000-0001-7429-4062 |b 13 |
| 700 | 1 | _ | |a Deleidi, Michela |0 P:(DE-2719)2810385 |b 14 |
| 700 | 1 | _ | |a Astolfi, Annalisa |0 0000-0002-2732-0747 |b 15 |
| 700 | 1 | _ | |a Pession, Andrea |b 16 |
| 773 | _ | _ | |a 10.1038/s42003-023-04813-2 |g Vol. 6, no. 1, p. 431 |0 PERI:(DE-600)2919698-X |n 1 |p 431 |t Communications biology |v 6 |y 2023 |x 2399-3642 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/257582/files/DZNE-2023-00458.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/257582/files/DZNE-2023-00458.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:257582 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 0 |6 P:(DE-2719)9000667 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2811884 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 14 |6 P:(DE-2719)2810385 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2023-10-27 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b COMMUN BIOL : 2022 |d 2023-10-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2023-04-12T15:13:06Z |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2023-04-12T15:13:06Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-27 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-27 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2022-11-12 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b COMMUN BIOL : 2022 |d 2023-10-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-27 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2022-11-12 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2023-04-12T15:13:06Z |
| 920 | 1 | _ | |0 I:(DE-2719)1210011 |k AG Deleidi |l Mitochondria and Inflammation in Neurodegeneration |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1210011 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|